.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Central Drugs Standard Control Organisation has granted marketing authorization for Qdenga, marking India's first approved dengue vaccine. Developed by Takeda, this two-dose live-attenuated vaccine offers protection for individuals aged 4 to 60 without requiring prior serological screening.
A multi-center Lancet study reveals over 21% of school-going Indian teenagers face moderate-to-high substance use risk. Geographic, digital, and environmental drivers highlight the urgent need for targeted clinical screening, regulatory enforcement, and peer-led interventions in school settings.
Deepinder Goyal's healthtech startup Temple is raising capital at a $500 million valuation and pricing its temporal wearable at Rs 80,000. Worn on the side of the forehead, the device tracks microvascular blood flow and real-time Entropy to monitor physiological stress, metabolic expenditure, and recovery.
The Food Safety and Standards Authority of India (FSSAI) has rejected industry appeals and directed beverage manufacturers to remove the term 'energy drink' and unapproved therapeutic claims within 90 days. This regulation aims to curb misbranding and ensure clear labeling across commercial food products.
A recent national survey highlights that 52% of bacteriologically positive tuberculosis cases in India present without typical symptoms. Health experts emphasize targeted radiological screening, early contact tracing, and expanding preventive treatment to achieve nationwide elimination goals.
